mHealth Israel

Coming to you from Glasgow, Stockholm and London: Europe MedTech Regulatory & Go-To-Market Workshop, with Edward Staunton, Fredrik Johansson and Mel Wallace. Tuesday, January 27th, 9-11am, Tel Aviv.

Cut through the noise of EU MDR, IVDR, and market access challenges. Experts with decades of experience share their practical regulatory and GTM best practices. Venue is Herzog Towers, 6 Sadeh, TLV.

Key Sections:
• Breakdown of the EU regulatory landscape, including compliance
• Guidance on classification, documentation, timelines and BUDGET
• Hospital pilot structures that prove cost savings in real workflows
• Economic cases tailored to payer and hospital incentives

This hands-on workshop will help you avoid regulatory and Go-To-Market hurdles and make Europe a launchpad, instead of a bottleneck.

Title: Europe MedTech Regulatory & GTM Workshop, with Edward Staunton, Fredrik Johansson and Mel Wallace
Speakers: Edward Staunton, Director, Regulatory Affairs & Quality, Clinigen.
Fredrik Johansson, Director, Business Development, Commercial Strategy, Clinigen
Mel Wallace, Vice President, Clinical Supplies Management, Clinigen
Time: 9-11am (9:30 start)
Venue: Herzog Towers, 6 Sadeh, Tel Aviv
MC: Goel Jasper, FINN Partners
Agenda:
9:00-9:30 Registration and networking
9:30-9:35 Welcome Remarks, Goel Jasper
9:35-9:40 mHealth Israel Introductory Remarks
9:40-9:50 Introduction to Clinigen, Mel Wallace, VP, Clinical Supplies Management
9:50-10:25 EU MedTech Regulatory Workshop, led by Edward Staunton
10:25-10:50 EU MedTech Go-to-Market insights, Frederik Johanssen

See you on Tuesday, January 27th, 9-11am at Herzog Towers, 6 Sadeh, TLV, for Europe MedTech Regulatory & GTM Workshop, with Edward Staunton, Fredrik Johansson and Mel Wallace.

May 5-7, Singapore: Investor meetings + HealthTechX Asia (see confirmed speakers in the photos)

Join mHealth Israel for a Singapore healthtech delegation, May 5-7, with two components:

• Singapore, May 5th: Half day meetings with local healthtech investors and half day of meetings with prominent corporates (targets include SingHealth, Olympus, Hoya...to be confirmed)
• Regional Hospitals, May 6-7: Pavilion at HealthTechX Asia. Each company has their own exhibition space, 10 companies total. Opportunitity to present. Some introductions arranged by the organizers and the Economic Attache. Venue: Sands Expo & Convention Centre, 10 Bayfront Avenue, Singapore

Some of the key themes and sessions at HealthTechX Asia include:
• AI for Clinical Decision Support & Workflow Automation
• Smart Hospitals & Digital Infrastructure Modernisation
• National Digital Health Policy & Data Governance
• Funding, Scaling & Value-Based Care Models
Confirmed Presenters:

• Colin Lim, CIO & CDO, Ministry of Health Singapore
• Charlene Liew, Director, AI Office, Changi General Hospital
• Christine Ng, Partner, Vertex Ventures

· Chien-Chang Lee - CIO, Ministry of Health and Welfare of Taiwan, Taiwan
· Dr.Ravi Sachdev - Chief Clinical Informatics Officer, Tan Tock Seng Hospital, Singapore

Evening activities planned for both May 5 and May 6.

Pavillion Layout: See photo section

Cost : $2,000 USD (Non-negotiable; Includes conference access; Excludes fliight and hotel)

Deadline: February 15

To reserve: levi.shapiro@gmail.com; WhatsApp: +972.52.3424.149

JAPAN HealthTech Accelerator
Powered by mHealth Israel and the Kizna Growth Framework©

Application Deadline: Feb 1st
Interview Period: Jan 22-28 (Tel Aviv)
Eligibility: Market ready Israeli healthtech companies, with at least $5m raised in equity / grants
Program: 5 online sessions (half focused on Japan HealthTech), weekly mentoring / assignments, Israel demo day, culminating in five day Tokyo residence featuring meetings with Japanese corporates, investors and government officials
Japan Residence (March 23-27): Meeting with the following:
- 20 Japanese corporates (including at least 5 Pharmas)
- 15 Japan-based healthtech investors
- 3 relevant government agencies
Accommodations: mHealth coporate rate at 5 star Sheraton / Miyako. JPY 23,000 (double occupancy); JPY 21,000 (single occupancy

Background: The Kizna (“bond / connection” in Japanese) Japan HealthTech Accelerator© is a six-week, systematic program for ultra-high potential, market-ready, growth stage Israeli healthtech companies to achieve success in Japan. There is no cost to participate. Kizna is eligible for equity compensation tied to joint milestones.

Why: Japan is the world #3 medical device market. Despite the scope of the opportunity, Israel has a minimal presence, ranking a disappointing #40 among countries exporting to Japan. Kizna combines a structured and systematic acceleration model (Kizna Growth Framework©) with a robust network of relationships and track record securing local partnerships.

Participating Companies: Executive leadership (Founder preferred) from 10 market-ready, Israeli healthtech companies. Includes Medical Device, Pharma, BioConvergence, Digital Health, FoodTech, etc.

Kizna Growth Framework© (5 week, structured, online acceleration program, tailored to Japan market conditions, featuring 2 hour weekly sessions complimented by 1 hours of offline work)
Modules: Japan Healthcare Market / Regulation / Reimbursement / Business Culture, Customer Discovery, Product Development, Digital Marketing, UX, Business Model / Plan, MVP, Pitching, Japan Go-To-Market, Structuring Partnerships, Negotiation, Fundraising

Methodology: Hybrid online / residential; Combining theoretical frameworks with hands-on mentoring and business development.

• Online component (5 weeks) using the proprietary Kizna Growth Framework© developed over several years with dozens of startups.
• Weekly online workshops, supplemented with 1.5 hours of weekly offline mentoring.
• Israel Demo Day at the conclusion of the 5 week online program.
• Weeklong Tokyo residential experience, March 23-27
  - Optional guided tourism near Tokyo, March 21-22
• Japan Investors Demo Day

Mentors: 30+ Tokyo-based mentors spanning finance, technology, investment, government and other key sectors. This group can provide valuable insights and introductions.

Past Results: Kizna has an unrivaled track record of bridging Israel / Japan and securing corporate partnerships on behalf of Israeli HealthTech companies.

Principal Partners, Japan:

• JETRO, the Japan External Trade Organization, a government department tasked with encouraging trade, investment and collaboration between Japan and other countries.
• FujiFilm (world leader in imaging and medical devices)
• Astellas (#2 Japanese pharma)

Company Participation Fee: $2500, excluding flight, hotel and travel expenses. Companies may also pay via equity options, but at higher exchange.

Team:
Gali Einav, PhD
• Co-Founder, Vetted VC Accelerator; General Partner, Vetted VC
• Program Head, Adelson School of Entrepreneurship, Reichman University
• Professor of Entrepreneurship, Yeshiva University
• Director, Digital Research, NBC Universal
• Advisory Board: Nielsen Innovate Fund; Yeshiva University Innovation Lab
• MA, Hebrew University; PhD, Columbia University

Levi Shapiro
• Founder and Chair, mHealth Israel (12,000+ Israeli tech entrepreneurs)
• Board Member: 4 startups
• General Partner, Veritas Ventures, Gemini Israel Partners
• Founder, 3 startups
• MNC Experience: IBM (Europe), Toyota (Japan)
• Tulane, Cornell, MIT (MBA)

Oren Kaplan
• Meitav (Israel’s largest investment house by AUM), Member of the Board and Founder, Meitav Global Markets
• Co-Founder / CEO, Sharing Alpha (Trip Advisor for Limited Partner investors; Acquired)
• Textbook author, “Behavioral Finance”
• Dealroom manager, Bank Otsar Hahayal and Bank Hapoalim
• UCL (Economics), Tel Aviv University / Wharton (MBA)

Amir Melnikov
• Head of R&D, International Program Manager, Directorate of Defense Research & Development
• Executive Officer, MEIMAD (110m NIS venture capital fund)
• R&D and Engineering Team Leader, Israel Defense Force
• Researcher, Superconductivity and Magnetic Measurements Institute, Bar Ilan University
• Bar Ilan (Physics), Reichman (MBA), Tokyo Institute of Technology (MA, Engineering)

To Apply: Contact Levi.Shapiro@gmail.com; +972.52.3424.149 to schedule a Zoom discussion or f2f meeting in Tel Aviv (Jan 21-30).